Literature DB >> 1635128

Current urological practice: routine urological examination and early detection of carcinoma of the prostate.

I M Thompson1, E J Zeidman.   

Abstract

With the increasing incidence of carcinoma of the prostate, the interest in early diagnosis through screening has dramatically increased. Several organizations, including the American Urological Association (AUA) and the American Cancer Society, have promulgated recommendations on suggested early detection methods. To determine the current practice patterns of United States urologists, a survey was sent to a random sample of 10% of all urologist members of the AUA. The survey was designed to determine what are current recommendations for an annual urological checkup for older men, what tests should be included in screening for carcinoma of the prostate and what age groups of men should undergo prostate cancer screening. A total of 562 surveys was returned, constituting a 4.7% sample of all urologist members of the AUA. The use of digital rectal examination was unanimously recommended for the urological examination as well as for prostate cancer detection. Prostate specific antigen was recommended by a majority of respondents for both situations. Screening was recommended for men ages 50 to 80 years. Demographic factors had a significant role in clinical recommendations by urologists.

Entities:  

Mesh:

Year:  1992        PMID: 1635128     DOI: 10.1016/s0022-5347(17)36585-0

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

1.  Variation in recommendations for cancer screening among primary care physicians in New Mexico.

Authors:  C J Herman; R M Hoffman; K K Altobelli
Journal:  J Community Health       Date:  1999-08

2.  Comparative clinical features of stage A1 and stage A2 prostate cancers. Is the concept of stage A changing from the current status?

Authors:  K Kunimi; T Amano; S W Lee; H Fuse; T Uchibayashi; K Miyazaki; M Ohkawa
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

3.  Prostate cancer: to screen or not to screen?

Authors:  F H Schröder
Journal:  BMJ       Date:  1993-02-13

4.  Who has screening mammography? Results from the 1994-1995 National Population Health Survey.

Authors:  F Tudiver; E Fuller-Thomson
Journal:  Can Fam Physician       Date:  1999-08       Impact factor: 3.275

5.  Screening for prostate cancer. How can patients give informed consent?

Authors:  K G Marshall
Journal:  Can Fam Physician       Date:  1993-11       Impact factor: 3.275

6.  Pharmacotherapy for benign prostatic hyperplasia.

Authors:  P Narayan; R Indudhara
Journal:  West J Med       Date:  1994-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.